Progressive renal vascular proliferation and injury in obese zucker rats

Microcirculation

Volumn 17, Issue 4, 2010, Pages 250-258

  Iliescu, Radu ^a   Chade, Alejandro R ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrosis; Inflammation; Kidney; Microcirculation; Obesity

Indexed keywords

ENDOTHELIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; IN VIVO STUDY; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; KIDNEY INJURY; LEAN BODY WEIGHT; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; ZUCKER RAT;

ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; HUMANS; IMAGING, THREE-DIMENSIONAL; INTERLEUKIN-6; KIDNEY; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; RATS; RATS, ZUCKER; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; X-RAY MICROTOMOGRAPHY;

RATTUS;

EID: 77951697821     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2010.00020.x     Document Type: Article

References (36)

1. Hedley AA, Ogden CL, Johnson CL, et al. (2004). Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (23 2847 2850. (Pubitemid 38747805)
2. Eckel RH, Barouch WW, Ershow AG 2002). Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation 105 (24 2923 2928.
3. Kramer H 2006). Obesity and chronic kidney disease. Contrib Nephrol 151 : 1 18. (Pubitemid 44298221)
4. -(2007). Prevalence of chronic kidney disease and associated risk factors - United States, 1999-2004. MMWR Morb Mortal Wkly Rep, 3, 56 (8 161 165.
5. Bosma RJ, Krikken JA, Homan van der Heide JJ, et al. (2006). Obesity and renal hemodynamics. Contrib Nephrol 151 : 184 202.
6. Rutkowski P, Klassen A, Sebekova K, et al. (2006). Renal disease in obesity: the need for greater attention. J Ren Nutr 16 (3 216 223. (Pubitemid 43975009)
7. Temm C, Dominguez JH 2007). Microcirculation: nexus of comorbidities in diabetes. Am J Physiol Renal Physiol 293 (2 F486 F493. (Pubitemid 47358118)
8. Costa C, Incio J, Soares R 2007). Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10 (3 149 166. (Pubitemid 47305203)
9. Chade AR, Krier JD, Galili O, et al. (2007). Role of renal cortical neovascularization in experimental hypercholesterolemia. Hypertension 50 (4 729 736. (Pubitemid 47442738)
10. Chade AR, Bentley MD, Zhu X, et al. (2004). Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol 15 (7 1816 1825. (Pubitemid 38822060)
11. Zucker LM 1965). Hereditary obesity in the rat associated with hyperlipemia. Ann N Y Acad Sci 131 (1 447 458.
12. Zucker LM, Antoniades HN 1972). Insulin and obesity in the Zucker genetically obese rat "fatty". Endocrinology 90 (5 1320 1330.
13. Iliescu R, Cucchiarelli VE, Yanes LL, et al. (2007). Impact of androgen-induced oxidative stress on hypertension in male SHR. Am J Physiol Regul Integr Comp Physiol 292 (2 R731 R735. (Pubitemid 46207723)
14. Reckelhoff JF, Yokota SD, Baylis C 1992). Renal autoregulation in midterm and late-pregnant rats. Am J Obstet Gynecol 166 (5 1546 1550.
15. Chade AR, Rodriguez-Porcel M, Grande JP, et al. (2002). Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106 (9 1165 1171. (Pubitemid 34970861)
16. Chade AR, Best PJ, Rodriguez-Porcel M, et al. (2003). Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. Kidney Int 64 (3 962 969. (Pubitemid 37013832)
17. Chalmers L, Kaskel FJ, Bamgbola O 2006). The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv Chronic Kidney Dis 13 (4 352 364. (Pubitemid 44512239)
18. Foster MC, Hwang SJ, Larson MG, et al. (2008). Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 52 (1 39 48. (Pubitemid 351853265)
19. Henegar JR, Bigler SA, Henegar LK, et al. (2001). Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12 (6 1211 1217.
20. Ramkumar N, Cheung AK, Pappas LM, et al. (2004). Association of obesity with inflammation in chronic kidney disease: a cross-sectional study. J Ren Nutr 14 (4 201 207. (Pubitemid 39360975)
21. Pozdzik AA, Salmon IJ, Husson CP, et al. (2008). Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol Dial Transplant 23 : 2480 2491.
22. Kelly KJ, Wu P, Patterson CE, et al. (2008). LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes. Am J Physiol Renal Physiol 294 (5 F1136 F1145.
23. McClintock JY, Wagner EM 2005). Role of IL-6 in systemic angiogenesis of the lung. J Appl Physiol 99 (3 861 866.
24. Nakao S, Kuwano T, Ishibashi T, et al. (2003). Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins. J Immunol 170 (11 5704 5711. (Pubitemid 36617863)
25. Norrby K 1996). TNF-alpha and de novo mammalian angiogenesis. Microvasc Res 52 (1 79 83. (Pubitemid 26245695)
26. Johnson PR, Stern JS, Horwitz BA, et al. (1997). Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. Am J Clin Nutr 66 (4 890 903.
27. Gerwins P, Skoldenberg E, Claesson-Welsh L 2000). Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 34 (3 185 194. (Pubitemid 30320963)
28. Rodriguez-Porcel M, Zhu XY, Chade AR, et al. (2006). Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension. Am J Physiol Heart Circ Physiol 290 (3 H978 H984.
29. Park YW, Kang YM, Butterfield J, et al. (2004). Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am J Pathol 165 (6 2087 2098. (Pubitemid 39578386)
30. Masuda Y, Shimizu A, Mori T, et al. (2001). Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 159 (2 599 608. (Pubitemid 32751090)
31. Banday AA, Marwaha A, Tallam LS, et al. (2005). Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats. Diabetes 54 (7 2219 2226. (Pubitemid 40911287)
32. Kretzler M, Schroppel B, Merkle M, et al. (1998). Detection of multiple vascular endothelial growth factor splice isoforms in single glomerular podocytes. Kidney Int Suppl 67 : S159 S161. (Pubitemid 28405703)
33. Percy C, Pat B, Poronnik P, et al. (2005). Role of oxidative stress in age-associated chronic kidney pathologies. Adv Chronic Kidney Dis 12 (1 78 83. (Pubitemid 40255607)
34. Percy CJ, Brown L, Power DA, et al. (2009). Obesity and hypertension have differing oxidant handling molecular pathways in age-related chronic kidney disease. Mech Ageing Dev 130 (3 129 138.
35. Kang DH, Hughes J, Mazzali M, et al. (2001). Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12 (7 1448 1457. (Pubitemid 32666327)
36. Kang DH, Johnson RJ 2003). Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 12 (1 43 49. (Pubitemid 36092314)